SCHEDULE OF OPERATIONS, ASSETS AND CAPITAL EXPENDITURES FOR OUR BUSINESS SEGMENTS (Details) - USD ($)		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information [Line Items]
Net revenue		$ 23,434,096	$ 18,536,638
Cost of goods sold		1,834,967	1,890,046
Selling, general and administrative		21,440,610	16,192,259
Research and development		1,114,138	946,298
Depreciation and amortization		1,124,410	1,105,420
Change in fair value of earnout liabilities			(65,678)
Other expense	[1]	1,447,354	267,336
Net loss		(3,527,383)	(1,799,043)
Segment Adjusted EBITDA		657,969	311,421
Sanara Surgical [Member]
Segment Reporting Information [Line Items]
Net revenue		23,434,096	18,536,638
Cost of goods sold		1,834,967	1,890,046
Selling, general and administrative		19,129,208	15,592,747
Research and development		950,359	578,980
Depreciation and amortization		688,571	698,502
Change in fair value of earnout liabilities			(103,782)
Other expense	[1]	1,446,096	267,336
Net loss		(615,105)	(387,191)
Segment Adjusted EBITDA		2,695,058	1,228,480
THP [Member]
Segment Reporting Information [Line Items]
Net revenue
Cost of goods sold
Selling, general and administrative		2,311,402	599,512
Research and development		163,779	367,318
Depreciation and amortization		435,839	406,918
Change in fair value of earnout liabilities			38,104
Other expense	[1]	1,258
Net loss		(2,912,278)	(1,411,852)
Segment Adjusted EBITDA		$ (2,037,089)	$ (917,059)

[1] For the three months ended March 31, 2025, other expense included interest expense, share of losses from equity method investments offset by interest income and gain on disposal of property and equipment. For the three months ended March 31, 2024, other expense included interest expense.